A Randomized Clinical Trial of Secondary Prevention Among Women Hospitalized with Coronary Heart Disease

被引:13
|
作者
Mosca, Lori [1 ]
Christian, Allison H.
Mochari-Greenberger, Heidi
Kligfield, Paul [2 ]
Smith, Sidney C., Jr. [3 ]
机构
[1] Columbia Univ, Prevent Cardiol Program, New York Presbyterian Hosp, Med Ctr, New York, NY 10032 USA
[2] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
[3] Univ N Carolina, Chapel Hill, NC USA
关键词
RISK-FACTOR MODIFICATION; LIPID-LOWERING-THERAPY; CASE-MANAGEMENT; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; UNITED-STATES; LIFE-STYLE; CHOLESTEROL; PROGRAM;
D O I
10.1089/jwh.2009.1481
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Secondary prevention improves survival, yet implementation is suboptimal. We tested the impact of a systematic hospital-based educational intervention vs. usual care to improve rates of adherence to secondary prevention guidelines among women hospitalized with coronary heart disease (CHD), according to their ethnic status. Methods: Women (n=304, 52% minorities) hospitalized with CHD were randomly assigned to a systematic secondary prevention educational intervention vs. usual care. Adherence to goals for smoking cessation, weight management, physical activity, blood pressure <140/90 mm Hg, low-density lipoprotein cholesterol (LDL-C) <100 mg/dL (2.59 mmol/L), and use of aspirin/anticoagulants, beta-blockers, and angiotensin-converting enzyme (ACE) inhibitors were assessed at 6 months. Results: On admission, minority women were less likely than white women to meet the goals for blood pressure (OR 0.46, 95% CI 0.26-0.80), LDL-C (OR 0.57, CI 0.33-0.94), and weight management (OR 0.40, 95% CI 0.20-0.82). There was no difference between the intervention and usual care groups in a summary score of goals met at study completion; however, minority women in the intervention group were 2.4 times more likely (95% CI 1.13-5.03) to reach the blood pressure goal at 6 months compared with minority women in usual care. White women in the intervention group were 2.86 times more likely (95% CI 1.06-7.68) to report use of beta-blockers at 6 months compared with white women in usual care. In a logistic regression model, the interaction term for ethnic status and group assignment was significant for achieving the blood pressure goal (p=0.009). Conclusions: A healthcare systems approach to educate women about secondary prevention and blood pressure control may differentially benefit ethnic minority women compared with white women.
引用
收藏
页码:195 / 202
页数:8
相关论文
共 50 条
  • [1] Adherence to secondary prevention lifestyle goals among women hospitalized with coronary heart disease.
    Linfante, AH
    Smith, SC
    Mosca, L
    CIRCULATION, 2004, 109 (07) : E91 - E91
  • [2] Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
    Hulley, S
    Grady, D
    Bush, T
    Furberg, C
    Herrington, D
    Riggs, B
    Vittinghoff, E
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07): : 605 - 613
  • [3] The AUStralian MEDiterranean Diet Heart Trial (AUSMED Heart Trial): A randomized clinical trial in secondary prevention of coronary heart disease in a multiethnic Australian population: Study protocol
    Itsiopoulos, Catherine
    Kucianski, Teagan
    Mayr, Hannah L.
    van Gaal, William J.
    Angel Martinez-Gonzalez, Miguel
    Vally, Hassan
    Kingsley, Michael
    Kouris-Blazos, Antigone
    Radcliffe, Jessica
    Segal, Leonie
    Brazionis, Laima
    Salim, Agus
    Tierney, Audrey C.
    O'Dea, Kerin
    Wilson, Andrew
    Thomas, Colleen J.
    AMERICAN HEART JOURNAL, 2018, 203 : 4 - 11
  • [4] Azithromycin for the secondary prevention of coronary heart disease events - The WIZARD study: A randomized controlled trial
    O'Connor, CM
    Dunne, MW
    Pfeffer, MA
    Muhlestein, JB
    Yao, L
    Gupta, S
    Benner, RJ
    Fisher, MR
    Cook, TD
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (11): : 1459 - 1466
  • [5] Impacts of Clinical Pharmacist Intervention on the Secondary Prevention of Coronary Heart Disease: A Randomized Controlled Clinical Study
    Xu, Huimin
    Zou, Jie
    Ye, Xiaoli
    Han, Jiayun
    Gao, Lan
    Luo, Shunbin
    Wang, Jingling
    Huang, Chunyan
    Yan, Xiaofeng
    Dai, Haibin
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [6] Secondary prevention of coronary heart disease in women: A call to action
    Miller, AP
    Oparil, S
    ANNALS OF INTERNAL MEDICINE, 2003, 138 (02) : 150 - 151
  • [7] Secondary prevention in coronary heart disease
    Haq, IU
    Minnis, RC
    Jackson, PR
    Yeo, WW
    Ramsay, LE
    JOURNAL OF HUMAN NUTRITION AND DIETETICS, 1996, 9 (05) : 363 - 371
  • [8] Secondary prevention of coronary heart disease
    Zafari, AM
    Wenger, NK
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1998, 79 (08): : 1006 - 1017
  • [9] The Role of Statins for the Primary and Secondary Prevention of Coronary Heart Disease in Women
    Tziomalos, Konstantinos
    Kakafika, Anna I.
    Athyros, Vasilios G.
    Karagiannis, Asterios
    Mikhailidis, Dimitri P.
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (10) : 1054 - 1062
  • [10] Effect of Gender, Caregiver, on Cholesterol Control and Statin Use for Secondary Prevention Among Hospitalized Patients With Coronary Heart Disease
    Hammond, Gmerice
    Mochari-Greenberger, Heidi
    Liao, Ming
    Mosca, Lori
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (11): : 1613 - 1618